Abstract
The QRS interval of 56 out of 75 (74.7%) HIV-infected, drug-experienced patients (66.7% men) increased during treatment with boosted or unboosted atazanavir by a median 5 ms (interquartile range 0-9; P <0.0001); the PR and the QTc intervals did not change significantly. New asymptomatic bundle branch blocks were observed in four patients; one subject with a baseline first-degree atrioventricular block developed symptomatic bradyarrhythmia while receiving atenolol. The electrocardiographic monitoring of patients treated with atazanavir seems advisable.
| Original language | English |
|---|---|
| Pages (from-to) | 1648-1651 |
| Number of pages | 4 |
| Journal | AIDS (London, England) |
| Volume | 21 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Jul 2007 |
ASJC Scopus subject areas
- Immunology
- Immunology and Allergy
Fingerprint Dive into the research topics of 'Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir'. Together they form a unique fingerprint.
Cite this
Gianotti, N., Guffanti, M., Galli, L., Margonato, A., Chiaravalli, G., Bigoloni, A., Lazzarin, A., & Castagna, A. (2007). Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir. AIDS (London, England), 21(12), 1648-1651. https://doi.org/10.1097/QAD.0b013e32826fbc6a